- $37.09m
- $17.20m
- $12.29m
Elutia Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Elutia Confirms No Material Impact From Global Tariffs
Brief: Elutia Inc May Offer & Sell Up To $50.0 Million Of Shares Of Class A Common Stock - SEC Filing
Brief: Elutia Announces GPO Agreement With Advantus Health Partners To Expand Access To EluPro
Brief: Elutia Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Elutia Inc reports results for the quarter ended December 31 - Earnings Summary
Elutia Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Elutia Signs Elupro GPO Agreement With Southern Strategic Sourcing Partners
Brief: Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier
Elutia Inc reports results for the quarter - Earnings Summary
Elutia Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Elutia Inc Announced First Patient Implant Of Elupro(®)
Elutia Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Elutia Announces $13.26 Million Registered Direct Offering
Brief: Elutia Announces FDA Clearance Of Elupro In Patients With Implantable Cardiac Pacemakers And Defibrillators
Elutia Inc expected to post a loss of 41 cents a share - Earnings Preview
Elutia Inc reports results for the quarter ended in December - Earnings Summary
Brief: Elutia Reports Fourth Quarter And Full Year 2023 Financial Results
Brief: Elutia Says Co Regained Compliance With Nasdaq Listing Requirements